相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Marcondes Alves B. Silva et al.
CLINICAL SCIENCE (2015)
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Petar M. Seferovic et al.
EUROPEAN HEART JOURNAL (2015)
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease
Bertram Pitt et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics
Henry Krum et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Beta-blocker therapy and prognosis of heart failure patients with new-onset diabetes mellitus
A. Garcia-Egido et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
Faiez Zannad et al.
LANCET (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure
Alessandra Dei Cas et al.
JACC-HEART FAILURE (2015)
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Silvio E. Inzucchi et al.
DIABETES CARE (2015)
Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial)
Muthiah Vaduganathan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Fibrosis and heart failure
Ana Maria Segura et al.
HEART FAILURE REVIEWS (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart
Jia Zhao et al.
WORLD JOURNAL OF DIABETES (2014)
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial
Aldo P. Maggioni et al.
EUROPEAN HEART JOURNAL (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Benjamin M. Scirica et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
A. Cas et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2013)
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel et al.
PHARMACOLOGICAL REVIEWS (2013)
Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control
Bryan Wai et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Six-year prognosis of diabetic patients with coronary artery disease
Savina Nodari et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
David Preiss et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome
Katie Ayers et al.
HYPERTENSION (2012)
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled study
Wolfram Doehner et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
E. Imai et al.
DIABETOLOGIA (2011)
Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure
Masayuki Yamaji et al.
AMERICAN HEART JOURNAL (2010)
Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients ≥70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS])
Rudolf A. de Boer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Intramyocardial Fibroblast Myocyte Communication
Rahul Kakkar et al.
CIRCULATION RESEARCH (2010)
Nebivolol Haemodynamic Effects and Clinical Significance of Combined beta-Blockade and Nitric Oxide Release
Otto Kamp et al.
DRUGS (2010)
Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options
Ashish Aneja et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production
Vivek P. Singh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Diastolic stiffness of the failing diabetic heart - Importance of fibrosis, advanced glycation end products, and myocyte resting tension
Loek van Heerebeek et al.
CIRCULATION (2008)
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles
K. Swaminathan et al.
DIABETOLOGIA (2008)
Clinical epidemiology of heart failure
Arend Mosterd et al.
HEART (2007)
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
Christian Torp-Pedersen et al.
HEART (2007)
Fibrosis in heart disease:: understanding the role of transforming growth factor-β1 in cardiomyopathy, valvular disease and arrhythmia
R Khan et al.
IMMUNOLOGY (2006)
Myocardial structure and function differ in systolic and diastolic heart failure
L van Heerebeek et al.
CIRCULATION (2006)
Glycated proteins stimulate reactive oxygen species production in cardiac myocytes - Involvement of Nox2 (gp91phox)-containing NADPH oxidase
M Zhang et al.
CIRCULATION (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes - A meta-analysis of randomized clinical trials
H Abuissa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure
S Yusuf et al.
CIRCULATION (2005)
The association between glucose abnormalities and heart failure in the population-based Reykjavik study
IS Thrainsdottir et al.
DIABETES CARE (2005)
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF
PC Deedwania et al.
AMERICAN HEART JOURNAL (2005)
Insulin stimulates endogenous angiotensin II production via a mitogen-activated protein kinase pathway in vascular smooth muscle cells
ML Tuck et al.
JOURNAL OF HYPERTENSION (2004)
The incidence of congestive heart failure in type 2 diabetes
GA Nichols et al.
DIABETES CARE (2004)
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
AH Barnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The effect of diabetes on outcomes of patients with advanced-heart failure in the BEST trial
M Domanski et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy
BJ Davis et al.
DIABETOLOGIA (2003)
Anti hypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control
H Holzgreve et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus
S Nodari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats
ZM Cao et al.
KIDNEY INTERNATIONAL (2001)
Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure
E Erdmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2001)
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus -: Results from the ATLAS trial
L Rydén et al.
EUROPEAN HEART JOURNAL (2000)
分享论文
